viimane versioon :
19/11/2024
uurimisrühmad - Royal Brisbane and Women\'s Hospital   pdf  
Austraalia
haigla
Royal Brisbane and Women\'s Hospital
Brisbane
Viited   Viited   (3)  
1
Compatibility of intravenous busulfan with BBraun giving sets, fludarabine and Posiflush.
Smith E. K., Shergold J.A., McWhinney B.C. (evonne.smith@health.qld.gov.au)
J Pharm Pract and Res - 2020 -
2
Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).
Ranganathan D, Naicker S,. Wallis S.C, Lipman J, . Ratanjee S.K, Roberts J.A (dwarakanathan.ranganathan@health.qld.gov.au)
Perit Dial Int - 2016 - ; 36:421-426.
3
The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration.
Semark, A.J, Venkatesh, K, McWhinney B.C, Pretorius, C, Roberts, J.A, Cohen J, Venkatesh B. (Andrew_Semark@health.qld.gov.au)
Crit Care Resusc - 2013 - ;15, 1: 63–66.

ingredientide nimekiri   molekulid uuritud   (9)  
vähiravimite Süsteravim Busulfan
antibiootikum Süsteravim Cefazolin sodium
antibiootikum Süsteravim Ceftazidime
antibiootikum Süsteravim Ciprofloxacin lactate
vähiravimite Süsteravim Fludarabine phosphate
antibiootikum Süsteravim Gentamicin sulfate
Põletikuvastane ravim Süsteravim Hydrocortisone sodium succinate
Anksiolüütiline ravim Süsteravim Midazolam hydrochloride
antibiootikum Süsteravim Vancomycin hydrochloride

  Mentions Légales